Hepatic tumors: Contrast agent-enhancement patterns with pulse-inversion harmonic US

Radiology

Volumn 216, Issue 2, 2000, Pages 411-417

  Kim, Tae Kyoung ^a   Choi, Byung Ihn ^a   Han, Joon Koo ^a   Hong, Hye Suk ^a   Park, Seong Ho ^a   Moon, Sung Gyu ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Angioma, gastrointestinal tract; Liver neoplasms; Liver neoplasms, secondary; Liver neoplasms, US; Ultrasound (US), contrast media; Ultrasound (US), harmonic study; Ultrasound (US), technology

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHOGRAPHY; HEMANGIOMA; HUMAN; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; PRIORITY JOURNAL;

EID: 0008158184     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.216.2.r00jl21411     Document Type: Article

References (23)

1. Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993; 189: 863-870.
2. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994; 192:401-406.
3. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997; 203:121-125.
4. Kim TK, Han JK, Kim AY, Choi BI. Limitations of characterization of hepatic hemangiomas using an ultrasound contrast agent (Levovist) and power Doppler ultrasound. J Ultrasound Med 1999; 18: 737-743.
5. Lopez-Ben R, Robbin ML, Weber TM, Smith JK, Needleman L, Berland LL. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study. J Ultrasound Med 1999; 18:109-116.
6. Tano S, Ueno N, Tomiyama T, Kimura K. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study. Clin Radiol 1997; 52:41-45.
7. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent - preliminary results. Radiology 1998; 209:135-140.
8. Tanaka S, Kitamra T, Fujita M, Yoshioka F. Value of contrast-enhanced color Doppler sonography in diagnosing hepatocellular carcinoma with special attention to the "color-filled pattern." J Clin Ultrasound 1998; 26:207-212.
9. Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol 1994; 163:1099-1104.
10. Maresca G, Barbaro B, Summaria V, et al. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions: the SH U 508 A (Levovist) experience. Radiol Med 1994; 87(suppl):41-49.
11. Ernst H, Hahn EG, Balzer T, Schlief R, Heyder N. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound 1996; 24:31-35.
12. Leen E, Angerson WJ, Warren HW, et al. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report. Br J Surg 1994; 81: 252-254.
13. Goldberg BB, Merton DA, Forsberg F, Liu JB, Rawool N. Color amplitude imaging: preliminary results using vascular sonographic contrast agents. J Ultrasound Med 1996; 15:127-134.
14. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35:58-71.
15. Burns PN, Wilson SR, Simpson DH, Chin CT, Lai X. Harmonic interval delay imaging: a new ultrasound contrast method for imaging the blood pool volume in the liver (abstr). Radiology 1998; 209(P):189.
16. Burns PN, Wilson SR, Muradali D, Powers JE, Fritzsch TT. Intermittent US harmonic contrast-enhanced imaging and Doppler improve sensitivity and longevity of vessel detection (abstr). Radiology 1996; 201(P):159.
17. Moriyasu F, Kono Y, Nada T, Matsumura T, Suginoshita Y, Kobayashi K. Flash echo (passive cavitation) imaging of the liver by using US contrast agents and intermittent scanning sequence (abstr). Radiology 1996; 201(P):196.
18. Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R. Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 1998; 171:1203-1206.
19. Kono Y, Moriyasu F, Mine Y, et al. Grayscale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol 1997; 32:120-125.
20. Burns PN, Wilson SR, Muradali D, Powers JE, Fritzsch TT. Microbubble destruction is the origin of harmonic signals from FS069 (abstr). Radiology 1996; 201(P):158.
21. Kamiyama N, Moriyasu F, Kono Y, Mine Y, Nada T, Yamazaki N. Investigation of the "flash echo" signal associated with a US contrast agent (abstr). Radiology 1996; 201(P):158.
22. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210:409-416.
23. Bollinger A, Putti P, Barras JP, et al. Red blood cell velocity in nailfold capillaries of men, measured by a television microscopy technique. Microvasc Res 1974; 7: 61-72.